Advanced / metastatic solid tumor
Clinical trials for Advanced / metastatic solid tumor explained in plain language.
Never miss a new study
Get alerted when new Advanced / metastatic solid tumor trials appear
Sign up with your email to follow new studies for Advanced / metastatic solid tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell booster shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new immune cell therapy (memory NK cells) combined with standard treatment for people with advanced solid tumors that have spread. The main goal is to check safety in a small group of 6 patients. If safe, more patients may be added to see if it help…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 1/2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Radioactive therapy targets Hard-to-Treat cancers in new trial
Disease control OngoingThis phase 2 trial is testing a radioactive drug called 177Lu-PSMA in 83 people with advanced or metastatic cancers that show up on a PSMA PET scan. The drug is given intravenously every 8 weeks for up to 4 cycles. The main goals are to check safety and see if the treatment can c…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase 2 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC